3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
1
Liver Neoplasms
1
Hypoxia
1
Colorectal Neoplasms
1
Cholangiocarcinoma
1
Interventions
Gemcitabine
13
Oxaliplatin
9
Capecitabine
6
lenvatinib
5
apatinib
5
Cisplatin
5
tislelizumab
4
Surgical Procedures, Operative
4
Radiofrequency Ablation
4
Neoadjuvant Therapy
4
Fluorouracil
4
toripalimab
3
sintilimab
3
Radiotherapy
3
Leucovorin
3
Irinotecan
3
regorafenib
2
pembrolizumab
2
durvalumab
2
camrelizumab
2
Stents
2
Photochemotherapy
2
Immunotherapy
2
Hepatectomy
2
Folfox protocol
2
Everolimus
2
Drug Therapy
2
Cholangiopancreatography, Endoscopic Retrograde
2
Blood Specimen Collection
2
1-phenyl-3,3-dimethyltriazene
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Cholangiocarcinoma
×
inositol trispyrophosphate
×
Clear all
NCT02528526
2015-08-19
OXY1A
University of Zurich
Phase 1/2
Unknown
69 enrolled